PCSA · ISSUER CIK 1533743
Processa Pharmaceuticals, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Processa Pharmaceuticals, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 11, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 202616:21 | Aug 8, 2026 | PCSA | Chief Executive Officer, Director | M · Exercise | — | +1,600 | 17,092 | +10% | — |